Observational Study of Patients With Diabetes Using Levemir® FlexPen®

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin detemir

Study type: Observational

Funder types: Industry

Identifiers

NCT00670683

NN304-1914

Details and patient eligibility

About

This study is conducted in Asia. This study is a prospective, open, uncontrolled, observational surveillance study with Levemir® FlexPen® conducted in Korea.

The aim of this observational study is to evaluate the short term and the long term safety and efficacy of Levemir® FlexPen®. The study is planned and conducted as per requirement from Korea Food and Drug Administration (KFDA).

Enrollment: 797 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diabetes Mellitus

Exclusion criteria

• Contra-indication based on local label

Trial design

797 participants in 1 patient group

A

Treatment:

Drug: insulin detemir